EARNEST Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-90
Closed -$10.1K 1119
2023
Q3
$10.1K Hold
90
﹤0.01% 631
2023
Q2
$13.1K Hold
90
﹤0.01% 574
2023
Q1
$11.6K Hold
90
﹤0.01% 592
2022
Q4
$11.5K Hold
90
﹤0.01% 592
2022
Q3
$9K Hold
90
﹤0.01% 620
2022
Q2
$9K Hold
90
﹤0.01% 641
2022
Q1
$12K Sell
90
-3
-3% -$362 ﹤0.01% 612
2021
Q4
$11K Hold
93
﹤0.01% 660
2021
Q3
$13K Hold
93
﹤0.01% 591
2021
Q2
$14K Hold
93
﹤0.01% 576
2021
Q1
$14K Hold
93
﹤0.01% 554
2020
Q4
$14K Hold
93
﹤0.01% 541
2020
Q3
$12K Hold
93
﹤0.01% 528
2020
Q2
$11K Hold
93
﹤0.01% 549
2020
Q1
$9K Hold
93
﹤0.01% 548
2019
Q4
$13K Hold
93
﹤0.01% 542
2019
Q3
$12K Hold
93
﹤0.01% 554
2019
Q2
$11K Hold
93
﹤0.01% 568
2019
Q1
$11K Hold
93
﹤0.01% 565
2018
Q4
$9K Hold
93
﹤0.01% 575
2018
Q3
$12K Hold
93
﹤0.01% 545
2018
Q2
$10K Hold
93
﹤0.01% 588
2018
Q1
$10K Hold
93
﹤0.01% 574
2017
Q4
$11K Buy
+93
New +$10.5K ﹤0.01% 535
2017
Q1
Sell
-93
Closed -$9K 930
2016
Q4
$9K Buy
+93
New +$9.97K ﹤0.01% 557

Other funds holding ZBH

EARNEST Partners's ZBH Position: Q4 2023 in Review

EARNEST Partners sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 90 shares — an estimated $10.1K sold.

EARNEST Partners first reported a position in ZBH in Q4 2016 and held it in 25 quarters. The position peaked at $14K in Q2 2021. 1,032 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • EARNEST Partners reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 90 Zimmer Biomet shares in Q4 2023, an estimated $10.1K.
  • EARNEST Partners first reported a position in Zimmer Biomet in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Zimmer Biomet position peaked at $14K in Q2 2021.
  • 1,032 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.